In fact, it is well known that PD-L1 expression increases in advanced stages of the diseases as reported by Sundara Y et al: 13% in primary tumours, 25% in local relapses tissue and 48% in metastatic (p = 0.002) [12]. The gene discussed is CD274; the disease is neoplasm.